Each vial is designed to support product and batch-level verification on arrival
Its effects, however, are still being studied through various research, which is why GHK-Cu has not been approved by the FDA as of yet
Frequently Asked Questions Research Use Only: This product is for laboratory research purposes only
Key facts What it is: traditional, patient-specific pharmacy compounding authorized by section 503A of the Federal Food, Drug, and Cosmetic Act
CJC-1295 with DAC: research has shown sustained, dose-dependent increases in GH and IGF-I in healthy adults, with the Teichman trial reporting the compound was safe and relatively well tolerated under ascending single doses and weekly or biweekly schedules
Whether that broader coverage is valuable depends on the specific research question